Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Thymoma × Ramucirumab × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Thymoma 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Metastatic Small Intestinal Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Taxes 2 Paclitaxel 2 Carboplatin 2 Ramucirumab 1 Proton Therapy 1 Prednisone 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03694002 2025-10-30

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed

21 enrolled 17 charts

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡